Yoshiyuki Kagawa Selected Research

Yoshiyuki Kagawa Research Topics

Disease

14	Epilepsy (Aura) 01/2022 - 01/2011
7	Neoplasms (Cancer) 05/2018 - 07/2004
4	Hyperammonemia 12/2019 - 09/2012
3	Body Weight (Weight, Body) 12/2019 - 04/2015
3	Vomiting 05/2018 - 01/2014
3	Diabetes Mellitus 05/2011 - 04/2004
2	Alzheimer Disease (Alzheimer's Disease) 09/2021 - 01/2021
2	Nausea 05/2018 - 02/2014
1	Seizures (Absence Seizure) 01/2022
1	Tachycardia (Tachyarrhythmias) 12/2021
1	Bradycardia 12/2021
1	Atrioventricular Block 12/2021
1	Intellectual Disability (Idiocy) 10/2021
1	Dementia (Dementias) 09/2021
1	Weight Loss (Weight Reduction) 08/2021
1	Cerebral Infarction 01/2021
1	Myoclonic Epilepsies (Myoclonic Encephalopathy) 01/2020
1	Choroidal Neovascularization 12/2019
1	Hyponatremia 12/2019
1	Dermatitis 01/2019
1	Inflammation (Inflammations) 12/2018
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2018
1	Frontal Lobe Epilepsy (Epilepsy, Supplementary Motor) 01/2018
1	Neutropenia 01/2018
1	Dyslipidemias (Dyslipidemia) 11/2016
1	Drug Resistant Epilepsy 06/2015
1	Rheumatoid Arthritis 05/2015
1	Insulin Resistance 01/2015
1	Glucose Intolerance 01/2015
1	Diarrhea 01/2014
1	Common Cold 01/2014
1	Generalized Epilepsy 06/2013

Drug/Important Bio-Agent (IBA)

8	Phenytoin (Dilantin)FDA LinkGeneric 12/2018 - 01/2011
7	Cytochrome P-450 CYP3AIBA 09/2021 - 11/2011
7	Anticonvulsants (Antiepileptic Drugs)IBA 12/2019 - 01/2012
6	Phenobarbital (Luminal)FDA Link 12/2019 - 01/2012
5	perampanelIBA 10/2021 - 01/2017
5	Valproic Acid (Depakote)FDA LinkGeneric 01/2020 - 01/2012
5	Cytochrome P-450 CYP2C19IBA 01/2020 - 01/2011
5	Carbamazepine (Tegretol)FDA LinkGeneric 12/2019 - 01/2012
4	Pharmaceutical PreparationsIBA 01/2022 - 06/2003
4	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 09/2021 - 11/2011
4	EnzymesIBA 01/2021 - 01/2012
3	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 09/2021 - 01/2011
3	Clobazam (HR 376)IBA 01/2020 - 06/2013
3	Topiramate (Topamax)FDA LinkGeneric 01/2018 - 09/2012
3	LipidsIBA 11/2016 - 05/2009
3	AmmoniaIBA 12/2015 - 09/2012
3	Oxycodone (Oxycontin)FDA LinkGeneric 02/2014 - 11/2011
2	Donepezil (Aricept)FDA LinkGeneric 09/2021 - 01/2021
2	6-O-desmethyl donepezilIBA 09/2021 - 01/2021
2	Prochlorperazine (Compazine)FDA LinkGeneric 05/2018 - 02/2014
2	CreatinineIBA 01/2018 - 07/2004
2	Carbonic Anhydrase InhibitorsIBA 12/2015 - 06/2013
2	Lamotrigine (Lamictal)FDA LinkGeneric 06/2015 - 01/2012
2	Tacrolimus (Prograf)FDA LinkGeneric 05/2015 - 04/2004
2	Cytochrome P-450 CYP2C9IBA 04/2015 - 01/2011
2	Glucose (Dextrose)FDA LinkGeneric 01/2015 - 04/2004
2	TabletsIBA 10/2012 - 11/2011
2	Biomarkers (Surrogate Marker)IBA 05/2011 - 08/2010
2	Vancomycin FDA LinkGeneric 02/2005 - 06/2003
1	rufinamide FDA Link 01/2022
1	1,4-dihydropyridine (dihydropyridine)IBA 12/2021
1	azelnidipineIBA 12/2021
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 09/2021
1	Capsules (Microcapsules)IBA 08/2021
1	PowdersIBA 08/2021
1	3,4-dehydrocilostazolIBA 01/2021
1	NitrogenIBA 01/2021
1	Cilostazol (Pletal)FDA LinkGeneric 01/2021
1	Urea (Carbamide)FDA LinkGeneric 01/2021
1	Lacosamide FDA Link 10/2020
1	stiripentolIBA 01/2020
1	Antipsychotic Agents (Antipsychotics)IBA 12/2019
1	SodiumIBA 12/2019
1	BenzodiazepinesIBA 12/2019
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2019
1	ZincIBA 01/2019
1	Ointments (Pastes)IBA 01/2019
1	Petrolatum (Vaseline)FDA Link 01/2019
1	C-Reactive ProteinIBA 12/2018
1	AntiemeticsIBA 05/2018
1	ProlactinIBA 05/2018
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2018
1	CholesterolIBA 11/2016
1	HDL CholesterolIBA 11/2016
1	Uridine Diphosphate (UDP)IBA 06/2015
1	Glucuronosyltransferase (UDP Glucuronosyltransferase)IBA 06/2015
1	sulthiame (sultiam)IBA 04/2015
1	Messenger RNA (mRNA)IBA 01/2015
1	Insulin ReceptorIBA 01/2015
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2015
1	Proteins (Proteins, Gene)FDA Link 01/2015
1	Insulin (Novolin)FDA Link 01/2015
1	oryeongsanIBA 01/2014
1	Zonisamide (Zonegran)FDA LinkGeneric 06/2013

Therapy/Procedure

5	Therapeutics 10/2021 - 01/2011
2	Drug Therapy (Chemotherapy) 08/2021 - 07/2004
1	Drug Tapering 12/2018
1	Intravenous Administration 01/2018